Compare HYI & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HYI | QSI |
|---|---|---|
| Founded | 2010 | 2013 |
| Country | United States | United States |
| Employees | N/A | 145 |
| Industry | Investment Managers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 136.2M | 161.8M |
| IPO Year | N/A | N/A |
| Metric | HYI | QSI |
|---|---|---|
| Price | $10.78 | $0.73 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $1.00 |
| AVG Volume (30 Days) | 68.2K | ★ 2.8M |
| Earning Date | 01-01-0001 | 05-14-2026 |
| Dividend Yield | ★ 9.59% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $618.07 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.44 | $0.69 |
| 52 Week High | $12.12 | $3.10 |
| Indicator | HYI | QSI |
|---|---|---|
| Relative Strength Index (RSI) | 48.56 | 36.98 |
| Support Level | $10.44 | N/A |
| Resistance Level | $11.21 | $1.11 |
| Average True Range (ATR) | 0.13 | 0.05 |
| MACD | 0.03 | -0.00 |
| Stochastic Oscillator | 64.15 | 24.67 |
Western Asset High Yield Defined Opps. is a non-diversified, limited-term, closed-end management investment company. The company's investment objective is to provide high income and seek capital appreciation. The fund invests a majority of its net assets in a portfolio of high-yield corporate fixed-income securities issued or originated by U.S. or foreign public or private corporations and other business entities, with varying maturities.
Quantum-Si Inc is a life sciences company focused on proteomics research and analytical technologies. It develops single-molecule detection platforms designed to enable next-generation protein sequencing (NGPS) and large-scale protein analysis. Its technology supports massively parallel sequencing of proteins and can also be applied to the study of nucleic acids, providing tools for researchers and clinical applications in molecular analysis. The company's revenue is derived from sales of products and services.